Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-27

Clinical Trial Update: Comparison of 3Mixtatin Pulpotomy and Metapex Pulpectomy in Primary Molars With Irreversible Pulpitis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing 3Mixtatin Pulpotomy with Metapex Pulpectomy in primary molars affected by irreversible pulpitis; recruitment has not started ye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 3Mixtatin (3Mixtatin paste (metronidazole, ciprofloxacin, minocycline))
  • Metapex (calcium hydroxide with iodoform paste)

Snippet

Sponsor: Cairo University | Conditions: Irreversible Pulpitis, Primary Teeth | Phase 1 | Status: NOT_YET_RECRUITING